期刊文献+

乳腺癌腋窝淋巴结转移的影响因素分析 被引量:1

Analysis of influencing factors of axillary lymph node metastasis in breast cancer
下载PDF
导出
摘要 目的探讨与乳腺浸润性癌腋窝淋巴结转移相关的临床病理特征,为术前预测乳腺癌腋窝淋巴结转移提供参考因素。方法回顾性分析2019年12月至2021年3月大连市妇女儿童医疗中心(集团)体育新城院区收治的70例乳腺癌患者的临床资料,收集患者年龄、肿瘤大小、病理分型、分子分型、病理分级、原发肿瘤灶数、微乳头结构及脉管浸润与否的信息。通过多因素分析影响腋窝淋巴结转移的危险因素。结果70例乳腺癌患者中,发生腋窝淋巴结转移29例,未转移41例。转移组与未转移组的肿瘤大小及脉管浸润与否比较,差异有统计学意义(P<0.05),而两组的年龄、病理分型、分子分型、病理分级、原发肿瘤灶数及是否伴有微乳头结构比较,差异无统计学意义(P>0.05)。多因素分析结果显示,肿瘤大小≥3.5 cm(β=1.829,OR=6.226,P=0.021,95%CI=1.315~29.490)及脉管浸润(β=2.578,OR=13.171,P<0.001,95%CI=3.861~44.937)是影响腋窝淋巴结转移的独立危险因素。结论肿瘤大小(≥3.5 cm)及脉管浸润是乳腺癌腋窝淋巴结转移的独立危险因素。临床可针对危险因素实现乳腺癌患者的精准化治疗。 Objective To investigate the clinicopathological features associated with axillary lymph node metastasis in invasive breast cancer,and to provide reference factors for preoperative prediction of axillary lymph node metastasis in breast cancer.Methods The clinical data of 70 patients with invasive breast cancer admitted to Dalian Women and Children Medical Center(Group)Sports New Town Campus from December 2019 to March 2021 were retrospectively analyzed.The information of patients′age,tumor size,pathological type,molecular type,pathological grade,number of primary tumor foci,micropapillary structure and vascular invasion were collected.The risk factors for axillary lymph node metastasis were analyzed by multivariate analysis.Results Among 70 patients with breast invasive cancer,29 cases had axillary lymph node metastasis and 41 cases had no metastasis.There were statistically significant differences in tumor size and vascular invasion between the metastatic group and the non-metastatic group(P<0.05).There were no significant differences in age,pathological type,molecular type,pathological grade,number of primary tumor foci and whether accompanied by micropapillary structure between the two groups(P>0.05).Multivariate analysis showed that the tumor size was≥3.5 cm(β=1.829,OR=6.226,P=0.021,95%CI=1.315~29.490)and vascular infiltration(β=2.578,OR=13.171,P<0.001,95%CI=3.861~44.937)were independent risk factors for axillary lymph node metastasis.Conclusion Tumor size(≥3.5 cm)and vascular invasion are independent risk factors for axillary lymph node metastasis in breast cancer.And precise treatment of breast cancer patients can be achieved according to the risk factors.
作者 于水 王伟 YU Shui;WANG Wei(Department of Pathology,Dalian Women and Children Medical Center(Group)Sports New Town Campus,Liaoning Province,Dalian116037,China;Department of Pathology,Dalian Women and Children Medical Center(Group)Chunliu Obstetrics and Gynecology Hospital Area,Liaoning Province,Dalian116033,China)
出处 《中国当代医药》 CAS 2022年第12期74-76,81,共4页 China Modern Medicine
关键词 乳腺浸润性癌 腋窝淋巴结 转移 危险因素 Invasive carcinoma of breast Axillary lymph nodes Transfer Risk factors
  • 相关文献

参考文献12

二级参考文献78

  • 1郭晓静,陈凌,郎荣刚,范宇,付丽.乳腺浸润性微乳头状癌的病理学特征与淋巴结转移的关系[J].中华病理学杂志,2006,35(1):8-12. 被引量:34
  • 2Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC ran- domised trial comparing sentinel node biopsy with standard axil- lary treatment in the management of patients with early breast cancer[J]. Breast Cancer Res Treat,2006,95 (3):279-293. DOI: 10.1007/s 10549 -005 -9025 -7.
  • 3Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node re- section compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer:, overall survival findings from the NSABP B-32 randomised phase 3 trial [J]. Lancet Oncol,2010,11 (10):927-933. DOI:10.1016/S1470-2045 (10)70207-2.
  • 4Ashikaga T, Krag DN, Stephanie R. et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection[J]. J Surg Oncol,2010,102 (2):111-118. DOI: l O.l OO2/jso.21535.
  • 5Meretoja TJ, Leidenius MH, Heikkila PS, et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer[J]. J Natl Cancer Inst,2012,104 (24):1888-1896. DOI: 10.1093/jnci/djs455.
  • 6Delpech Y, Brieou A, Lousquy R, et al. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study[J]. Ann Surg Oncol,2013,20 (8):2556-2561. DOI:10.1245/ s 10434-O13-2917-6.
  • 7Giuliano AE, Morrow M, Duggal S, et al. Should ACOSOG Z001 1 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer[J]. Clin Exp Metastasis,2012,29 (7):687-692. DOI:10.1007/s 10585-012-9515-z.
  • 8Friedman D, Gipponi M, Murelli F, et al. Predictive factors ofnon-sentinel lymph node involvement in patients with invasive breast cancer andsentinel node micrometastases [J]. Anticancer Res,2013,33 ( 10 ) :4509-4514.
  • 9Tausch C, Taucher S, Dubsky P, et al. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto tri- als of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)[J]. Ann Surg Oncol,2012,19(6):1808-1817. DOI:10.1245/ s10434-011-2189-y.
  • 10Galimberti V, Cole BF, Zurrida S, et al. IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases[J]. Lancet Oncol,2013,14 (4) :297-305. DOI:10.1016/S 1470-2045 ( 13 )70035- 4.

共引文献163

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部